Evaluation of ESBL (Extended Spectrum Beta-Lactamase) Producing Escherichia Coli Isolated from Patients with Urinary Tract Infection by Phenotypic and Genotypic Methods
Preprint
- 29 April 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Urinary Tract Infection (UTI) is the most common bacterial infection in the world. E. coli is the predominant Pathogen. This study evaluates the prevalence of ESBL in E. colis isolated from patients with urinary tract infections with phenotypic and genotypic methods.Methods: This descriptive-analytical study was done on 155 isolates of E. coli isolated from patients with urinary tract infection who had received the study consent. After accurate identification of E. coli strains. ESBL production for Escherichia coli isolates which are resistant to ceftriaxone or ceftazidime was evaluated by CDT method. TEM, SHV and CTX-M genes were identified by PCR.Results: The results showed that 30 strains from 155 strains of E. coli had ESBL. Strains of ESBL producer were more in males was lower in educated persons. 38.9% of ESBL producer had antibiotic use, 29.9% -producing Escherichia hospitalization and 31.6% uti history. The highest level of drug allergy in the ESBL was related to nitrofurantoin, and the highest resistance was related to cefazolin, co-trimoxazole. The CTX-M and the CTX-M15 gene were found in 92.7% and 57.1% of cases, respectively; also the SHV and TEM genes were not found in any of ESBL-producing Escherichia coli strains. Most therapeutic response in patients was related to cefexime, ciprofloxacin and nitrofurantoin 27.4%, 26% 21.9%, respectively.Conclusion: This study showed that the history of antibiotic use, hospitalization, uti related to increase of ESBL-producing in E. coli isolates., the CTMX-M gene is the most common gene in ESBL-producing E. coli strains.Keywords
All Related Versions
This publication has 16 references indexed in Scilit:
- Therapeutic potential of medicinal plants for the management of urinary tract infection: A systematic reviewClinical and Experimental Pharmacology and Physiology, 2019
- Extended-spectrum β-lactamase producing E. coli in urinary tract infections: A two-center, cross-sectional study of prevalence, genotypes and risk factors in Amman, JordanJournal of Infection and Public Health, 2019
- Isolation of Extended-Spectrum β-lactamase- (ESBL-) Producing Escherichia coli and Klebsiella pneumoniae from Patients with Community-Onset Urinary Tract Infections in Jimma University Specialized Hospital, Southwest EthiopiaCanadian Journal of Infectious Diseases and Medical Microbiology, 2018
- Prevalence of Multidrug Resistance and Extended-Spectrum β-Lactamase Carriage of Clinical Uropathogenic Escherichia coli Isolates in Riyadh, Saudi ArabiaInternational Journal of Microbiology, 2018
- Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern –A hospital based cross sectional studyBMC Infectious Diseases, 2017
- Multi-drug resistant uropathogenic Escherichia coli and its treatment by Chinese medicineChinese Journal of Integrative Medicine, 2016
- Urinary tract infections: a retrospective, descriptive study of causative organisms and antimicrobial pattern of samples received for culture, from a tertiary care settingGERMS, 2016
- Symptom-based diagnosis of urinary tract infection in women: are we over-prescribing antibiotics?International Journal Of Clinical Practice, 2012
- Urinalysis and Urinary Tract Infection: Update for CliniciansInfectious Diseases in Obstetrics and Gynecology, 2001
- Development of a Long-Term Ascending Urinary Tract Infection Mouse Model for Antibiotic Treatment StudiesAntimicrobial Agents and Chemotherapy, 2000